Science Explorer Back to mapMap
Discussion
Researcher · Merck KGaA, Darmstadt (Germany) · Germany

Brian Elenbaas

Brian Elenbaas publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer-related Molecular Pathways, RNA modifications and cancer and DNA Repair Mechanisms.

ORCID 0000-0002-7892-6028 OpenAlex
World rank
#328,224
of 7,710,434 ranked researchers
Rank in Germany
#16,339
of 364,343
Works
56
Citations
7.5k
Citations per work
134.5
h-index
22
i10-index 24Top 28% in Molecular Biology
Brian Elenbaas

What does Brian Elenbaas research?

Brian Elenbaas's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (36%).

Life Sciences: 26 works · 47.2% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 47.2% of their workMolecular Biology: 20 works · 36.1% of their workCancer Research: 4 works · 7.4% of their workGenetics: 2 works · 3.7% of their workHealth Sciences: 20 works · 36.1% of their workMedicine: 20 works · 36.1% of their workOncology: 16 works · 28.7% of their workEpidemiology: 2 works · 3.7% of their workPathology and Forensic Medicine: 2 works · 3.7% of their workEverything else: 9 works · 16.7% of their workTHEIR WORKBrian Elenbaas56works
Life Sciences47%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2647.2%
    1. Medicine2036.1%
  3. Everything else916.7%
  1. 1Molecular Biology36% of their works
  2. 2Oncology29% of their works
  3. 3Cancer Research7% of their works
  4. 4Genetics4% of their works
  5. 5Epidemiology4% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Brian Elenbaas's research?

The keywords of their largest research topics: Cancer Therapy, Cell Cycle, p53, Chemotherapy, Homologous Recombination, m6A-seq, RNA methylation and DNA Damage.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Therapy162 topics
  2. Cell Cycle121 topic
  3. p53121 topic
  4. Chemotherapy92 topics
  5. Homologous Recombination92 topics
  6. RNA methylation91 topic
  7. m6A-seq91 topic
  8. DNA Damage51 topic
  9. Genomic Profiles51 topic
  10. Repair51 topic
  11. Small-Cell Lung Cancer51 topic
  12. BRCA Mutation41 topic
  13. Cancer Stem Cells41 topic
  14. DNA41 topic
  15. Gene Therapy41 topic
  16. PARP Inhibitors41 topic
  17. Topoisomerases41 topic
  18. Tumor Metastasis41 topic
  19. Viral Vectors41 topic

Where does Brian Elenbaas work?

Brian Elenbaas's main affiliation in the publication record is Merck KGaA, Darmstadt (Germany), Germany.

How many publications and citations does Brian Elenbaas have?

OpenAlex counts 56 works and 7,531 citations for Brian Elenbaas, an h-index of 22, ranking #328,224 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Brian Elenbaas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.